WebSep 1, 2024 · Patients were continued on 10 mg daily (5 mg daily for those ≥75 years or weight <60 kg). Patients who were treated conservatively after coronary angiography were maintained on their assigned study drug. Total number of enrollees: 4,018. Duration of follow-up: 1 year. Mean patient age: 65 years. WebJan 1, 2001 · The primary endpoints were a composite of cardiovascular death, myocardial infarction, or urgent target-vessel revascularization within 30 days of PCI and …
Ticagrelor With Aspirin or Alone in High-Risk Patients After …
http://cardiologytrials.org/detail/29/ WebAug 29, 2024 · Contribution To Literature: Highlighted text has been updated as of February 15, 2024. The TWILIGHT trial showed that short-duration DAPT (3 months) followed by ticagrelor monotherapy for 12 months results in less bleeding compared with longer-duration DAPT (additional 12 months) among patients undergoing PCI with a DES and at high … pictures for honest
Cost-effectiveness of clopidogrel in acute coronary syndromes in …
WebApr 22, 2024 · The openness and inclusivity of this approach set a new standard for trial reporting. ISCHEMIA showed that, at a median follow-up of 3.2 years, in patients with SIHD and moderate to severe ischemia, an initial invasive strategy did not reduce the risk of the primary end point of cardiovascular death, MI, hospitalization for unstable angina ... WebJun 29, 2024 · Findings of global registration trials, SURPASS-1, SURPASS-2, SURPASS-3, and SURPASS-5 were presented at the virtual 81st Scientific Sessions of the … WebRXFILES TRIAL SUMMARY A WWWMARTENS, L KOSAR MARCH 2016– .RXFILES.CA Page 2 ASA DOSE 7 The dose of ASA ranged from 75-325mg daily. The prescribed dose was at the discretion of the treating physician. In a subsequent publication,7 patients from PCI-CURE were stratified into three ASA dose groups: high dose (≥200mg, median dose … top golf meridian idaho